Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000826206 | SCV000967765 | pathogenic | Tuberous sclerosis syndrome | 2018-04-27 | criteria provided, single submitter | clinical testing | The p.Lys816X variant in TSC1 has been reported in one individual with tuberous sclerosis complex (TSC) in the tuberous sclerosis LOVD database (http://chromiu m.lovd.nl/LOVD2/TSC/home.php) and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 816, which is predicted to lead to a truncated or absent protein. Heterozygous loss of func tion of the TSC1 gene is an established disease mechanism in individuals with TS C. In summary, this variant meets criteria to be classified as pathogenic for tu berous sclerosis complex in an autosomal dominant manner based upon predicted im pact on the protein and absence in the general population. ACMG/AMP Criteria app lied: PVS1, PM2, PS4_Supporting. |